Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma

David S. Siegel, Meletios A. Dimopoulos, Heinz Ludwig, Thierry Facon, Hartmut Goldschmidt, Andrzej Jakubowiak, Jesus San-Miguel, Mihaela Obreja, Julie Blaedel, A. Keith Stewart

Research output: Contribution to journal › Article › peer-review

124 Scopus citations

Fingerprint

Dive into the research topics of 'Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences